Two different conditions are included in inflammatory bowel disease (IBD), Crohn's disease
(CD) and ulcerative colitis (UC), being distinguished by chronic recurrence of gut …

Background Ulcerative Colitis (UC) is an inflammatory condition affecting the colon with an
incidence of approximately 10‐20 per 100,000 per year. No existing intervention is effective …

Microorganisms present in the intestine possess proinflammatory or anti-inflammatory
activities which may modulate inflammatory bowel disease (IBD). The concepts followed by …

Background Ulcerative colitis is a chronic relapsing disease characterised by diffuse
mucosal inflammation limited to the colon. Current maintenance treatments have multiple …

Inflammatory bowel diseases (IBD) encompass ulcerative colitis (UC), Crohn's disease (CD)
and indeterminate colitis (IC), characterising chronic inflammation in the gastrointestinal …

There is a close relationship between the human host and the intestinal microbiota, which is
an assortment of microorganisms, protecting the intestine against colonization by …

Inflammatory bowel disease (IBD) is a result of chronic inflammation caused, in some part,
by dysbiosis of intestinal microbiota, mainly commensal bacteria. Gut dysbiosis can be …

Background Whether probiotics are beneficial at all stages of treatment in inflammatory
bowel disease or superior to placebo remains controversial. Methods Two reviewers …

Intestinal bacteria play a key role in inflammatory bowel disease. Probiotics attempt to
modify disease by favourably altering bacterial composition, immune status, and …

Background Probiotics are microorganisms that are ingested either in combination or as a
single organism in an effort to normalize intestinal microbiota and potentially improve …